Six minute walk test: a simple and useful test to evaluate functional capacity in patients with heart failure

[1]  Karl Swedberg,et al.  Six minute walk test. , 2005, European heart journal.

[2]  V. Burke,et al.  The 6-minute walk test does not reliably detect changes in functional capacity of patients awaiting cardiac transplantation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  K. Swedberg,et al.  Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. , 2005, European heart journal.

[4]  Harlan M Krumholz,et al.  The association of 6-minute walk performance and outcomes in stable outpatients with heart failure. , 2004, Journal of cardiac failure.

[5]  E. Foster,et al.  Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. , 2003, Journal of the American College of Cardiology.

[6]  L. Tavazzi,et al.  Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds--the TEMISTOCLE study. , 2003, American heart journal.

[7]  Grace Wu,et al.  The 6-minute walk test: how important is the learning effect? , 2003, American heart journal.

[8]  G. Gensini,et al.  Prognostic value of 6‐minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation , 2003, European journal of heart failure.

[9]  R. Canby,et al.  Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. , 2003, JAMA.

[10]  Milton Packer,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[11]  Stefan Sack,et al.  Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. , 2002, Journal of the American College of Cardiology.

[12]  G. Gensini,et al.  Prognostic value of 6-minute walk corridor testing in women with mild to moderate heart failure. , 2002, Italian heart journal : official journal of the Italian Federation of Cardiology.

[13]  L. Badano,et al.  Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure; the OSCUR study. Oucome dello Scompenso Cardiaco in relazione all'Utilizzo delle Risore. , 2001, European heart journal.

[14]  J. Daubert,et al.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. , 2001, The New England journal of medicine.

[15]  S. Anker,et al.  The 6-minute walk test and prognosis in chronic heart failure--the available evidence. , 2001, European heart journal.

[16]  L. Tavazzi,et al.  Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? , 2001, European heart journal.

[17]  L. Tavazzi,et al.  Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. , 2001, Journal of the American College of Cardiology.

[18]  D. Brooks,et al.  A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. , 2001, Chest.

[19]  A. Ferreira,et al.  Predictors of prognosis in patients with stable mild to moderate heart failure. , 2000, Journal of cardiac failure.

[20]  S. Yusuf,et al.  Functional capacity in patients with congestive heart failure. , 2000, Journal of cardiac failure.

[21]  V. Boddi,et al.  Comparison of different methods of functional evaluation in patients with chronic heart failure , 2000, European journal of heart failure.

[22]  J. Refsgaard,et al.  Divergent outcome between six minute walking test and maximal bicycle test during treatment with carvedilol in patients with mild to moderate heart failure , 2000 .

[23]  J. Refsgaard,et al.  Atrioventricular plane displacement in detecting benefit of carvedilol to patients with congestive heart failure. A Randomized, double-blinded, placebo-controlled study , 2000 .

[24]  S. Gerber,et al.  Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? , 2000, European heart journal.

[25]  S J Jay,et al.  Reference equations for the six-minute walk in healthy adults. , 2000 .

[26]  P. Poole‐Wilson The 6-minute walk. A simple test with clinical application. , 2000, European heart journal.

[27]  J. Butler,et al.  Pulmonary hypertension and exercise intolerance in patients with heart failure. , 1999, Journal of the American College of Cardiology.

[28]  L. Stevenson,et al.  The 6-min walk and peak oxygen consumption in advanced heart failure: aerobic capacity and survival. , 1999, American heart journal.

[29]  F. Martinez EXERCISE GAS EXCHANGE IN HEART DISEASE , 1999 .

[30]  G. Roul,et al.  Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? , 1998, American heart journal.

[31]  H. Ross,et al.  Clinical, Hemodynamic, and Cardiopulmonary Exercise Test Determinants of Survival in Patients Referred for Evaluation of Heart Failure , 1998, Annals of Internal Medicine.

[32]  L. Tavazzi,et al.  Reproducibility of the six-minute walking test in patients with chronic congestive heart failure: practical implications. , 1998, The American journal of cardiology.

[33]  A. Giordano,et al.  Assessment of oxygen uptake during the 6-minute walking test in patients with heart failure: preliminary experience with a portable device. , 1997, American heart journal.

[34]  A. Skene,et al.  Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure , 1997, The Lancet.

[35]  D A Redelmeier,et al.  Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. , 1997, American journal of respiratory and critical care medicine.

[36]  L. Cahalin,et al.  The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. , 1996, Chest.

[37]  D. Mancini,et al.  Peak VO2is superior to 6 minute walk for the prediction of survival in patients with heart failure , 1996 .

[38]  M. Mathier,et al.  Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. , 1995, Journal of the American College of Cardiology.

[39]  R. Califf,et al.  788-2 Six Minute Walk Test Gives Prognostic Information in Severe Hear Failure , 1995 .

[40]  T. Mets,et al.  Captopril treatment of chronic heart failure in the very old. , 1994, Journal of gerontology.

[41]  Bittner,et al.  Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. , 1993, JAMA.

[42]  William J. Rogers,et al.  Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular Dysfunction , 1993 .

[43]  B. Massie,et al.  Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study. , 1993, Journal of the American College of Cardiology.

[44]  J. Cohn,et al.  Functional Capacity in Heart Failure Comparison of Methods for Assessment and Their Relation to Other Indexes of Heart Failure , 1993, Circulation.

[45]  T. Rector,et al.  Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure. , 1993, Journal of the American College of Cardiology.

[46]  P. Agostoni,et al.  Isolated ultrafiltration in moderate congestive heart failure. , 1993, Journal of the American College of Cardiology.

[47]  S. Chinn,et al.  Portable liquid oxygen and exercise ability in severe respiratory disability. , 1992, Thorax.

[48]  M. Landsman,et al.  Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. , 1992, The American journal of cardiology.

[49]  C. Stanford,et al.  Oxygen consumption during corridor walk testing in chronic cardiac failure. , 1992, European heart journal.

[50]  M. Pistolesi,et al.  Measurement of extravascular lung water. , 1991, Intensive care world.

[51]  J R Wilson,et al.  Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure , 1991, Circulation.

[52]  B. Pitt,et al.  Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. , 1989, Journal of the American College of Cardiology.

[53]  J. Cohn,et al.  Prognosis of congestive heart failure and predictors of mortality. , 1988, The American journal of cardiology.

[54]  G. Francis Clinical aspects of heart failure , 1986 .

[55]  P A Poole-Wilson,et al.  Six minute walking test for assessing exercise capacity in chronic heart failure. , 1986, British medical journal.

[56]  J. Franciosa,et al.  Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure. , 1985, American heart journal.

[57]  G. Guyatt,et al.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. , 1985, Canadian Medical Association journal.

[58]  E. Braunwald Heart Disease: A Textbook of Cardiovascular Medicine , 1992, Annals of Internal Medicine.

[59]  S. P. Gupta,et al.  Twelve-minute walking test for assessing disability in chronic bronchitis. , 1976, British medical journal.